NDC 0074-2605

Kaletra

Lopinavir And Ritonavir

Kaletra is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Lopinavir; Ritonavir.

Product ID0074-2605_0195c057-8795-448e-b1e4-c168d23e4301
NDC0074-2605
Product TypeHuman Prescription Drug
Proprietary NameKaletra
Generic NameLopinavir And Ritonavir
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2020-04-08
Marketing CategoryNDA / NDA
Application NumberNDA021906
Labeler NameAbbVie Inc.
Substance NameLOPINAVIR; RITONAVIR
Active Ingredient Strength200 mg/1; mg/1
Pharm ClassesBreast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], HIV Protease Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0074-2605-21

120 TABLET, FILM COATED in 1 BOTTLE (0074-2605-21)
Marketing Start Date2020-04-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0074-2605-21 [00074260521]

Kaletra TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021906
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2020-04-08

Drug Details

Active Ingredients

IngredientStrength
LOPINAVIR200 mg/1

Pharmacological Class

  • HIV Protease Inhibitors [MoA]
  • Protease Inhibitor [EPC]
  • P-Glycoprotein Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]
  • Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
  • HIV Protease Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitor [EPC]
  • Protease Inhibitor [EPC]
  • Cytochrome P450 3A Inhibitors [MoA]
  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Cytochrome P450 2C19 Inducers [MoA]
  • Cytochrome P450 3A Inducers [MoA]
  • P-Glycoprotein Inhibitors [MoA]
  • Breast Cancer Resistance Protein Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 1A2 Inducers [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 2B6 Inducers [MoA]
  • UDP Glucuronosyltransferases Inducers [MoA]

NDC Crossover Matching brand name "Kaletra" or generic name "Lopinavir And Ritonavir"

NDCBrand NameGeneric Name
0074-0522KaletraLopinavir and Ritonavir
0074-1575KaletraLopinavir and Ritonavir
0074-2605KaletraLopinavir and Ritonavir
0074-3956KaletraLopinavir and Ritonavir
0074-6799KaletraLopinavir and Ritonavir
11819-342KaletraLopinavir and Ritonavir
21695-362Kaletralopinavir and ritonavir
53808-0276Kaletralopinavir and ritonavir
55289-947KaletraLopinavir and Ritonavir
68258-1972KaletraKaletra
70518-0091KaletraKaletra
66336-624KaletraKaletra
68071-2348KaletraKaletra
31722-556Lopinavir and ritonavirLopinavir and ritonavir
31722-603Lopinavir and ritonavirLopinavir and ritonavir
42385-933Lopinavir and RitonavirLopinavir and Ritonavir
42385-934Lopinavir and RitonavirLopinavir and Ritonavir

Trademark Results [Kaletra]

Mark Image

Registration | Serial
Company
Trademark
Application Date
KALETRA
KALETRA
75465750 2451327 Live/Registered
ABBVIE INC.
1998-04-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.